BRPI0416205A - uso de antibióticos como adjuvantes de vacina - Google Patents
uso de antibióticos como adjuvantes de vacinaInfo
- Publication number
- BRPI0416205A BRPI0416205A BRPI0416205-6A BRPI0416205A BRPI0416205A BR PI0416205 A BRPI0416205 A BR PI0416205A BR PI0416205 A BRPI0416205 A BR PI0416205A BR PI0416205 A BRPI0416205 A BR PI0416205A
- Authority
- BR
- Brazil
- Prior art keywords
- adjuvant
- vaccine
- antibiotics
- azalide
- specifically
- Prior art date
Links
- 239000012646 vaccine adjuvant Substances 0.000 title abstract 3
- 229940124931 vaccine adjuvant Drugs 0.000 title abstract 3
- 239000003242 anti bacterial agent Substances 0.000 title abstract 2
- 229940088710 antibiotic agent Drugs 0.000 title abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 5
- 239000004599 antimicrobial Substances 0.000 abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000013566 allergen Substances 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/116—Polyvalent bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"USO DE ANTIBIóTICOS COMO ADJUVANTES DE VACINA". A presente invenção refere-se a uma composição adjuvante que compreende um agente anti-microbiano, especificamente uma azalida, em que o agente anti-microbiano atua como um adjuvante. Mais especificamente, a composição adjuvante é um adjuvante de vacina. A invenção descreve ainda uma vacina que compreende vários componentes compreendendo (a) pelo menos um antígeno e (b) pelo menos um agente anti-microbiano, especificamente uma azalida, em que a azalida atua como um adjuvante. Uma composição adjuvante ou vacina da presente invenção é útil na prevenção e tratamento de doenças causadas por um agente patogênico, uma célula cancerosa ou um alérgeno.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52409703P | 2003-11-21 | 2003-11-21 | |
PCT/IB2004/003694 WO2005049081A1 (en) | 2003-11-21 | 2004-11-08 | The use of anti biotics as vaccine adjuvants |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0416205A true BRPI0416205A (pt) | 2006-12-26 |
Family
ID=34619630
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0416205-6A BRPI0416205A (pt) | 2003-11-21 | 2004-11-08 | uso de antibióticos como adjuvantes de vacina |
Country Status (16)
Country | Link |
---|---|
US (1) | US20070141086A1 (pt) |
EP (1) | EP1689434A1 (pt) |
JP (1) | JP2007512312A (pt) |
KR (1) | KR100785601B1 (pt) |
CN (1) | CN1882360A (pt) |
AR (1) | AR047728A1 (pt) |
AU (1) | AU2004290982B2 (pt) |
BR (1) | BRPI0416205A (pt) |
CA (1) | CA2546195A1 (pt) |
IL (1) | IL175373A0 (pt) |
MX (1) | MXPA06005639A (pt) |
NO (1) | NO20062918L (pt) |
RU (1) | RU2322241C2 (pt) |
TW (1) | TW200526245A (pt) |
WO (1) | WO2005049081A1 (pt) |
ZA (1) | ZA200603065B (pt) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070077256A1 (en) | 1999-11-19 | 2007-04-05 | Los Angeles Biomedical Research Institute | Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
CA2502986C (en) | 2002-10-25 | 2011-08-23 | Foamix Ltd. | Cosmetic and pharmaceutical foam |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
FR2896416B1 (fr) * | 2006-01-24 | 2010-08-13 | Vetoquinol | Composition anti-infectieuse comprenant un compose de type pyrido (3,2,1-ij)-benzoxadiazine |
US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
WO2009090495A2 (en) | 2007-12-07 | 2009-07-23 | Foamix Ltd. | Oil and liquid silicone foamable carriers and formulations |
BRPI0822098A2 (pt) * | 2007-12-21 | 2015-06-30 | Glaxosmithkline Biolog Sa | Componente para uma vacina contra malária, vacina para malária, processo para a preparação do componente, uso do componente, e, método de tratar um paciente suscetível às infecções por plasmodium |
CA2760186C (en) | 2009-04-28 | 2019-10-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
MX359879B (es) | 2009-10-02 | 2018-10-12 | Foamix Pharmaceuticals Ltd | Composiciones tópicas de tetraciclina. |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
EP2528620B1 (en) * | 2010-01-28 | 2019-06-05 | Universiteit Gent | Salmonella vaccine |
UA114286C2 (uk) * | 2011-07-22 | 2017-05-25 | Общєство С Огранічєнной Отвєтствєнностью "Новамєдіка" | Спосіб лікування staphylococcus aureus |
AU2014240165A1 (en) * | 2013-03-14 | 2015-10-01 | Rongfu Wang | Methods and compositions for modulating regulatory T cell function |
WO2014144211A2 (en) | 2013-03-15 | 2014-09-18 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for treating fungal and bacterial pathogens |
CN103127098B (zh) * | 2013-03-22 | 2014-05-14 | 于法周 | 一种含有克拉维酸或其盐的抗癌药物组合物及制药用途 |
EP2926815A1 (en) * | 2014-04-03 | 2015-10-07 | Institut Curie | New derivatives of cephalosporin for treating cancer |
CN106999499A (zh) * | 2014-10-28 | 2017-08-01 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的用途 |
CN105616414B (zh) * | 2014-10-28 | 2019-03-05 | 湘北威尔曼制药股份有限公司 | 一种氧代哌嗪酰胺类化合物的新用途 |
CN104546863B (zh) * | 2015-02-09 | 2016-09-14 | 江苏澳格姆生物科技有限公司 | 头孢噻吩钠在制备抑制肿瘤细胞转移和扩散的药物中的应用 |
JP6838884B2 (ja) * | 2015-08-06 | 2021-03-03 | 日東電工株式会社 | 免疫誘導促進組成物及びワクチン医薬組成物 |
WO2017116049A1 (ko) * | 2015-12-31 | 2017-07-06 | 경북대학교 산학협력단 | 설폰아마이드계 화합물을 유효성분으로 포함하는 암의 치료 및 전이 억제용 약학적 조성물 |
WO2017155949A1 (en) | 2016-03-09 | 2017-09-14 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Methods and kits for use in preventing and treating vulvovaginal candidiasis |
MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
CN110302376A (zh) * | 2019-04-22 | 2019-10-08 | 荆门市动物疫病预防控制中心 | 一种禽流感疫苗佐剂及应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5929086A (en) * | 1996-05-10 | 1999-07-27 | Pharmacia & Upjohn Company | Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases |
HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
-
2004
- 2004-11-08 WO PCT/IB2004/003694 patent/WO2005049081A1/en active Application Filing
- 2004-11-08 KR KR1020067009852A patent/KR100785601B1/ko not_active IP Right Cessation
- 2004-11-08 MX MXPA06005639A patent/MXPA06005639A/es not_active Application Discontinuation
- 2004-11-08 CA CA002546195A patent/CA2546195A1/en not_active Abandoned
- 2004-11-08 JP JP2006540643A patent/JP2007512312A/ja not_active Withdrawn
- 2004-11-08 EP EP04798833A patent/EP1689434A1/en not_active Withdrawn
- 2004-11-08 AU AU2004290982A patent/AU2004290982B2/en not_active Expired - Fee Related
- 2004-11-08 US US10/595,784 patent/US20070141086A1/en not_active Abandoned
- 2004-11-08 BR BRPI0416205-6A patent/BRPI0416205A/pt not_active IP Right Cessation
- 2004-11-08 RU RU2006117339/15A patent/RU2322241C2/ru not_active IP Right Cessation
- 2004-11-08 CN CNA2004800341547A patent/CN1882360A/zh active Pending
- 2004-11-19 TW TW093135705A patent/TW200526245A/zh unknown
- 2004-11-19 AR ARP040104279A patent/AR047728A1/es not_active Application Discontinuation
-
2006
- 2006-04-18 ZA ZA200603065A patent/ZA200603065B/xx unknown
- 2006-05-01 IL IL175373A patent/IL175373A0/en unknown
- 2006-06-21 NO NO20062918A patent/NO20062918L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20062918L (no) | 2006-08-21 |
US20070141086A1 (en) | 2007-06-21 |
AR047728A1 (es) | 2006-02-15 |
ZA200603065B (en) | 2007-08-29 |
CN1882360A (zh) | 2006-12-20 |
KR20060091001A (ko) | 2006-08-17 |
KR100785601B1 (ko) | 2007-12-14 |
RU2006117339A (ru) | 2007-12-10 |
CA2546195A1 (en) | 2005-06-02 |
EP1689434A1 (en) | 2006-08-16 |
AU2004290982B2 (en) | 2008-06-19 |
RU2322241C2 (ru) | 2008-04-20 |
WO2005049081A1 (en) | 2005-06-02 |
IL175373A0 (en) | 2006-09-05 |
TW200526245A (en) | 2005-08-16 |
JP2007512312A (ja) | 2007-05-17 |
AU2004290982A1 (en) | 2005-06-02 |
MXPA06005639A (es) | 2006-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0416205A (pt) | uso de antibióticos como adjuvantes de vacina | |
BRPI0410503A (pt) | uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição | |
CL2013002106A1 (es) | Composicion inmunogenica de streptococcus pneumoniae que comprende 2 o mas conjugados de sacarido capsular de diferentes serotipos; vacuna que la comprende; procedimiento de fabricacion; y su uso para tratar o prevenir enfermedades causadas por la infeccion por streptococcus pneumoniae (div.sol.n°3625-2006). | |
PT1187629E (pt) | Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador | |
BRPI0612669B8 (pt) | composição imunogênica, vacina, composição, e composição liofilizada | |
BRPI0414062A (pt) | uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv | |
BRPI0509053A (pt) | composição farmacêutica anidra e uso de um agente siliconado e de uma composição | |
BRPI0114927B8 (pt) | composição de gel farmacêutica não aquosa para aplicação na pele, e, uso de uma composição | |
BRPI0608840B8 (pt) | composição farmacêutica compreendendo uma difenil uréia substituída por ômega-carboxiarila, e seu processo de preparação | |
ECSP034916A (es) | Oxazolidinonas substituidas para terapia de combinacion | |
NO20061912L (no) | Vaksinesammensetninger omfattende et interleukin 18 og saponin adjuvant system | |
ES2195169T3 (es) | Vacunas contra calmidias y composiciones inmunogenicas que contienen un antigeno de membrana externa y metodos para su preparacion. | |
BRPI0608439A2 (pt) | composições imunogênicas compreendendo lawsonia intracellularis | |
AR059688A1 (es) | Uso de alfa - toxina para tratar y prevenir las infecciones por staphylococcus | |
MA28106A1 (fr) | Compositions immunogenes | |
BRPI0519242A2 (pt) | uso derivados de 1-aminociclohexano para o tratamento de esclerose méltipla, instabilidade emocional e paralisia pseudobulbar | |
BR0209127A (pt) | compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
BRPI0500318A (pt) | processo para a preparação de uma composição cosmética, composição cosmética, processos para o tratamento cosmético das matérias queratìnicas, dispositivo para o condicionamento de uma composição cosmética e uso da composição | |
BRPI0409742A (pt) | uso de um agente anti-angiogênico, em combinação com um inibidor da famìlia src de tirosina quinases não-receptoras, produto de combinação, e, composição farmacêutica | |
BRPI0414386A (pt) | composto, métodos para fabricação do mesmo, para tratamento ou prevenção de uma doença, para ativação da função de er em uma célula óssea, para inibição de função de er em uma célula, para inibição da expressão de il-6, para inibição do crescimento de uma célula neoplásica expressando er, para prevenção de espermatogenese, para prevenção de um efeito reprodutivo adverso associados com exposição a uma falta de equilìbrio hormonal natural ou quìmica ambiental, e, composição | |
GT200400090A (es) | Nonadepsipeptidos acilados | |
BR0201524A (pt) | Tratamento de combinação para ansiedade e depressão | |
BR0211830A (pt) | Dose única de azitromicina | |
BR0117149A (pt) | Uso de um copolìmero para produzir uma forma farmacêutica contendo um peptìdio ou proteìna como agente ativo | |
BRPI0413157A (pt) | agente, kit, e, uso de um álcool alcoxilado |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |